weight
24 stories and discussions about weight, aggregated from every source we track.
How open-weight demand can support the useful life of NVIDIA GPU families. Selected figures and tables, limitations, and the full PDF.
TL;DR: We study the scaling laws of data weighting across in-house and open-weight LMs, finding non-monotonic behavior across scales. We vary the weight assi...
We’re on a journey to advance and democratize artificial intelligence through open source and open science.
Obesity may leave behind a cellular memory that pushes the body to regain lost weight.
A Blog post by Black Forest Labs on Hugging Face
Kernal Fit: how one IT professional lost the desk-job weight with small changes to eating habits. No gym, no heavy dieting. $9 ebook.
Open-weight GLiNER2.5-Decide in MLX Swift versus TypeSafe’s hosted Jev: what each offers, what the published benchmark compared, and local measurements: 7.6 ms per request at 0.85 GB with INT8.
See major speech-to-text engines tested on identical LibriSpeech and Earnings-22 audio with one scorer and paired-bootstrap confidence intervals.
Vercel data shows downloadable-weight models processing 56% of production AI Gateway tokens in August, while capturing only 14% of spending.
Laya vs Jev for typed AI decisions: why I run the open-weight model on my Mac, how it beat my router 37/40 to 33/40, and what that does not prove.
The weight of a television set has nothing at all to do with the clarity of its picture. Even if you measure to a tenth of a gram, this precise data is useless. Some people measure stereo equipment…
TL;DR: We study the scaling laws of data weighting across in-house and open-weight LMs, finding non-monotonic behavior across scales. We vary the weight assi...
TL;DR: We study the scaling laws of data weighting across in-house and open-weight LMs, finding non-monotonic behavior across scales. We vary the weight assi...
Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Spend tokens on judgment, not typing. An MCP-native autonomous SDLC pipeline: frontier models plan and review, local models implement — engineering discipline on a $20/month budget. - motock/fagan
Self-hosted gym & body-weight tracker — plan routines, log workouts (supersets, warm-ups, cardio), see which muscles are trained, fatigued or detrained, import from FitNotes/Strong/Hevy, passke...
The September 2026 AI Gateway production index covering data from August 2026: Open-weight models took the majority of token volume for the first time ever; Fable loses two-thirds of its spend share and Opus 5 tripled…
Notes on MiMo-V2.6 Pro’s GQA and sliding-window attention, agent training tasks, reward signals, and large RL batches.
Researchers published late-stage clinical trial data today for the latest obesity drug, retatrutide—expected to be the most powerful formula yet—and the results appear in line with high expectations. Patients with obesity on the highest retatrutide dose lost an average of 25 percent of their body weight after 80 weeks, and an average of 30 percent after an extension period to 104 weeks. Overall, more than a third of participants taking retatrutide lost 30 percent or more of their weight. The drug also proved effective at reducing knee pain (by up to 62 percent) in a subset of participants with obesity-linked knee osteoarthritis. It reduced the number of sleep apnea events per hour (by up to 57 percent) in a subset of participants with obesity-linked obstructive sleep apnea. The drug improved cardiometabolic measurements across the board, including blood pressure, triglycerides, and low-density lipoprotein cholesterol (bad cholesterol). At the start, more than a third of trial participants had prediabetes and, by the end, the condition had resolved in more than 90 percent of those participants. The trial began in 2023 and included 2,339 participants from 131 clinical trial sites in 11 countries. Participants were broken into four nearly equal groups, given either: 4 mg of retatrutide, 9 mg, 12 mg, or a placebo. Across all groups, the average starting weight was around 113 kg (250 pounds), and the average body mass index (BMI) was 40. For the subset analyses, 574 participants had knee osteoarthritis, and 243 had obstructive sleep apnea. The results appeared today in the New England Journal of Medicine . Read full article Comments